Literature DB >> 6270675

Functional unit of the low density lipoprotein receptor of fibroblasts: a 100,000-dalton structure with multiple binding sites.

T L Innerarity, E S Kempner, D Y Hui, R W Mahley.   

Abstract

The low density lipoprotein (apoprotein B,E) receptors of fibroblasts bind plasma lipoproteins that contain either the B (apo-B) or E (apo-E) apoproteins. These include the low density lipoproteins (LDL) containing apo-B and certain high density lipoproteins containing apo-E (e.g., the cholesterol-induced apo-E HDLc). The same receptor binds both LDL and apo-E HDLc, but the apo-E HDLc bind with much higher affinity. This higher affinity is due to the binding of apo-E HDLc to multiple receptor sites. One possible structural model for this receptor is that each apo-B,E receptor possesses a single binding site. Thus, the multiple binding of apo-E HDLc would require the recruitment of four independent receptors to bind to a single apo-E HDLc particle. A second model is that each receptor unit possesses multiple binding sites capable of binding one apo-E HDLc particle or four LDL particles. This study characterizes the apo-B,E receptors in situ in the membranes of fibroblasts by radiation inactivation. This technique allows one to determine the functional size of the receptor on the basis of the amount of radiation required to inactivate the structure. The larger the molecular size of the structure, the less ionizing radiation (generated by a linear accelerator) that will be required to abolish the receptor--ligand interaction. The functional size of the apo-B,E receptor is 106,000 Mr as determined with both LDL and apo-E HDLc binding after radiation inactivation. Furthermore, the data derived from radiation inactivation and Scatchard analysis indicate that each apo-B,E receptor has multiple binding sites and that each functional receptor unit, capable of binding one apo-E HDLc or four LDL particles, has a molecular weight of 106,000.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6270675      PMCID: PMC319793          DOI: 10.1073/pnas.78.7.4378

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts.

Authors:  T L Innerarity; R E Pitas; R W Mahley
Journal:  J Biol Chem       Date:  1979-05-25       Impact factor: 5.157

2.  Exchange of partners in glucagon receptor-adenylate cyclase complexes. Physical evidence for the independent, mobile receptor model.

Authors:  M D Houslay; J C Ellory; G A Smith; T R Hesketh; J M Stein; G B Warren; J C Metcalfe
Journal:  Biochim Biophys Acta       Date:  1977-06-02

3.  Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins.

Authors:  T L Innerarity; R W Mahley
Journal:  Biochemistry       Date:  1978-04-18       Impact factor: 3.162

4.  Characterization of the low density lipoprotein receptor in membranes prepared from human fibroblasts.

Authors:  S K Basu; J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1978-06-10       Impact factor: 5.157

Review 5.  Size determination of enzymes by radiation inactivation.

Authors:  E S Kempner; W Schlegel
Journal:  Anal Biochem       Date:  1979-01-01       Impact factor: 3.365

6.  The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations.

Authors:  D W Bilheimer; S Eisenberg; R I Levy
Journal:  Biochim Biophys Acta       Date:  1972-02-21

7.  Preparation and properties of plasma membrane and endoplasmic reticulum fragments from isolated rat fat cells.

Authors:  J Avruch; D F Wallach
Journal:  Biochim Biophys Acta       Date:  1971-04-13

8.  Purification of rat liver 5'-nucleotidase as a complex with sphingomyelin.

Authors:  C C Widnell
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

9.  Canine hyperlipoproteinemia and atherosclerosis. Accumulation of lipid by aortic medial cells in vivo and in vitro.

Authors:  R W Mahley; T L Innerarity; K H Weisgraber; D L Fry
Journal:  Am J Pathol       Date:  1977-04       Impact factor: 4.307

10.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

Authors:  A E Bolton; W M Hunter
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

View more
  6 in total

1.  Involvement of disulphide bonds in the renal sodium/phosphate co-transporter NaPi-2.

Authors:  Y Xiao; C J Boyer; E Vincent; A Dugré; V Vachon; M Potier; R Béliveau
Journal:  Biochem J       Date:  1997-04-15       Impact factor: 3.857

2.  Plasma high density lipoprotein subgroup distribution in rats fed diets with varying amounts of sucrose and sunflower oil.

Authors:  A T Høstmark; O Spydevold; E Lystad
Journal:  Lipids       Date:  1982-07       Impact factor: 1.880

3.  Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia.

Authors:  M R Wardell; S O Brennan; E D Janus; R Fraser; R W Carrell
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

4.  Mouse macrophage receptor for acetylated low density lipoprotein: demonstration of a fully functional subunit in the membrane and with purified receptor.

Authors:  D P Via; E S Kempner; L Pons; A E Fanslow; S Vignale; L C Smith; A M Gotto; H A Dresel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

5.  Radiation-inactivation studies on brush-border-membrane vesicles. General considerations, and application to the glucose and phosphate carriers.

Authors:  R Béliveau; M Demeule; H Ibnoul-Khatib; M Bergeron; G Beauregard; M Potier
Journal:  Biochem J       Date:  1988-06-15       Impact factor: 3.857

6.  Genetic studies of human apolipoproteins. X. The effect of the apolipoprotein E polymorphism on quantitative levels of lipoproteins in Nigerian blacks.

Authors:  B Sepehrnia; M I Kamboh; L L Adams-Campbell; C H Bunker; M Nwankwo; P P Majumder; R E Ferrell
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.